Abbott (ABT) Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences (EW)

Go back to Abbott (ABT) Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences (EW)

Abbott Agrees to Global Transcatheter Litigation Settlement with Edwards Lifesciences

July 13, 2020 4:15 PM EDT

ABBOTT PARK, Ill., July 13, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has reached an agreement with Edwards Lifesciences Corporation to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products.

The agreement will result in the dismissal of... More